SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001615774-18-001106
Filing Date
2018-02-13
Accepted
2018-02-13 15:51:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A s109040_sch13g.htm SC 13G/A 48911
  Complete submission text file 0001615774-18-001106.txt   50287
Mailing Address 712 FIFTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address
RAPP MICHAEL (Filed by) CIK: 0001405685 (see all company filings)

Type: SC 13G/A

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88971 | Film No.: 18603051
SIC: 2834 Pharmaceutical Preparations